Table 2. Cox regression model analysis for prognosis based on various clinical characteristics of NSCLC patients.
Factor | HR | 95% CI (univariate) | P value | miR-33a multivariate analysis | ||
---|---|---|---|---|---|---|
HR | 95% CI (multivariate) | P value | ||||
Age | 0.95 | 0.71–1.15 | 0.78 | |||
Gender | 0.88 | 0.54–1.26 | 0.36 | |||
Smoking history | 1.22 | 0.73–1.38 | 0.12 | |||
Lymph-node metastasis | 1.54 | 1.16–1.86 | 0.04 | 1.78 | 1.20–2.66 | 0.02 |
Tumor differentiation | 0.78 | 0.54–1.11 | 0.16 | |||
Histology | 1.19 | 0.88–1.24 | 0.11 | |||
TNM stage | 2.29 | 2.72–3.38 | 0.01 | 2.43 | 1.86–2.98 | 0.008 |
Invasion of lung membrane | 1.76 | 1.45–1.99 | 0.02 | |||
Vascular invasion | 0.91 | 0.68–1.24 | 0.75 | |||
Diameter (≥ 5 cm) | 2.56 | 2.03–3.45 | 0.001 | 3.17 | 2.26–5.03 | <0.001 |
Low miR-33a expression | 1.66 | 1.21–2.24 | 0.028 |